Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
NCT ID: NCT00589459
Last Updated: 2023-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
103 participants
OBSERVATIONAL
2001-10-01
2008-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
NCT00589355
Prediabetes and Metabolic Parameters Among Young Adults at Assiut University Hospital
NCT07259954
Coronary Artery Plaque Burden in Asymptomatic Danish Men Aged 65-75 Years and the Relation to Glycemic Status.
NCT04525508
The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care
NCT05553145
Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects
NCT02109835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
non-diabetic women with acute coronary syndrome (ACS)
No interventions assigned to this group
2
non-diabetic men with acute coronary syndrome (ACS)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 30 yrs
Exclusion Criteria
* ACS due to substance abuse or trauma
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Ethel F Donaghue Women's Health Investigator's Program at Yale
UNKNOWN
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yale University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara I Gulanski, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bridgeport Hospital
Bridgeport, Connecticut, United States
Yale Center for Clinical Investigation
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AHA
Identifier Type: -
Identifier Source: secondary_id
Donaghue Women's Health R02524
Identifier Type: -
Identifier Source: secondary_id
12258
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.